TY  - JOUR
AU  - Azor, Begona Rodriguez
AU  - Martin-Masot, Rafael
AU  - Khialani, Anita Dayaldasani
AU  - Fernandez-Martin, Jesus Maria
AU  - Fernandez, Carmen Gallego
AU  - Navas-Lopez, Victor Manuel
PY  - 2023
DO  - 10.1016/j.anpedi.2022.05.012
SN  - 1695-4033
UR  - http://hdl.handle.net/10668/21963
T2  - Anales de pediatria
AB  - Introduction and aims: The incidence of paediatric inflammatory bowel disease has increased in recent decades. The aim of the present study was to evaluate the role of proactive and serial monitoring of tumour necrosis factor (TNF) inhibitor levels to...
LA  - en
PB  - Ediciones Doyma
KW  - Paediatric Crohn disease
KW  - Inflammatory bowel disease
KW  - Therapeutic drug monitoring
KW  - Infliximab
KW  - Adalimumab
KW  - Inflammatory-bowel-disease
KW  - Adalimumab
KW  - Therapy
KW  - Experience
KW  - Moderate
KW  - Outcomes
KW  - Spain
KW  - Infliximab
KW  - Crohn Disease
KW  - Tumor Necrosis Factor Inhibitors
KW  - Prospective Studies
KW  - Inflammatory Bowel Diseases
KW  - Tumor Necrosis Factor-alpha
TI  - Proactive monitoring of anti-TNF agents improves follow-up of paediatric patients with Crohn disease
T2  - La monitorización proactiva de niveles de anti-TNF mejora el seguimiento de los pacientes pediátricos con enfermedad de Crohn.
TY  - research article
VL  - 98
ER  -